Literature DB >> 16695589

STUDIES IN METHIONINE AND SULFUR METABOLISM. I. THE FATE OF INTRAVENOUSLY ADMINISTERED METHIONINE, IN NORMAL INDIVIDUALS AND IN PATIENTS WITH LIVER DAMAGE.

L W Kinsell1, H A Harper, H C Barton, M E Hutchin, J R Hess.   

Abstract

Entities:  

Year:  1948        PMID： 16695589      PMCID： PMC439541          DOI： 10.1172/JCI102016

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  Rate of Disappearance From Plasma of Intravenously Administered Methionine in Patients With Liver Damage.

Authors:  L W Kinsell; H A Harper; H C Barton; G D Michaels; H A Weiss
Journal:  Science       Date:  1947-12-12       Impact factor: 47.728

2.  Plasma l-Methionine Levels Following Intravenous Administration in Humans.

Authors:  H A Harper; L W Kinsell; H C Barton
Journal:  Science       Date:  1947-10-03       Impact factor: 47.728
  2 in total
  16 in total

1.  The levels of individual free amino acids in the plasma of normal man at various intervals after a high-protein meal.

Authors:  E G FRAME
Journal:  J Clin Invest       Date:  1958-12       Impact factor: 14.808

2.  Amino acid metabolism in infectious hepatitis.

Authors:  D YI-YUNG HSIA; S S GELLIS
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

3.  Renal clearance of eighteen individual amino acids in human subjects.

Authors:  P D DOOLAN; H A HARPER; M E HUTCHIN; W W SHREEVE
Journal:  J Clin Invest       Date:  1955-08       Impact factor: 14.808

4.  Urinary excretion of amino acids in patients with cirrhosis of the liver and in normal adults.

Authors:  G J GABUZDA; R D ECKHARDT; C S DAVIDSON
Journal:  J Clin Invest       Date:  1952-11       Impact factor: 14.808

5.  URINARY EXCRETION OF AMINO ACIDS IN LIVER DISEASE.

Authors:  M S Dunn; S Akawaie; H L Yeh; H Martin
Journal:  J Clin Invest       Date:  1950-03       Impact factor: 14.808

6.  Studies in methionine metabolism; fasting plasma methionine levels in normal and hepatopathic individuals in response to daily methionine ingestion.

Authors:  L W KINSELL; H A HARPER
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

7.  Studies in methionine metabolism; the fate of intravenously administered S35-labeled-methionine in normal adult males, in patients with chronic hepatic disease, idiopathic hypoproteinemia and Cushing's syndrome.

Authors:  L W KINSELL; S MARGEN
Journal:  J Clin Invest       Date:  1950-02       Impact factor: 14.808

Review 8.  Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.

Authors:  E Pisi; G Marchesini
Journal:  Drugs       Date:  1990       Impact factor: 9.546

9.  Plasma and urinary amino acids in Laennec's cirrhosis.

Authors:  H H Zinneman; U S Seal; R P Doe
Journal:  Am J Dig Dis       Date:  1969-02

10.  The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia.

Authors:  Patricia M DiBello; Sanjana Dayal; Suma Kaveti; Dongmei Zhang; Michael Kinter; Steven R Lentz; Donald W Jacobsen
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.